Praxis Precision Medicines annual return on equity
2020
2021
2022
2023
2024
2025
Praxis Precision Medicines Return on Equity (ROE) Growth & History (PRAX)
Praxis Precision Medicines's return on equity was −45.83% for fiscal 2025.
View full Praxis Precision Medicines company overviewPraxis Precision Medicines annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −45.83% | +25.16 pp |
| 2024 | 2024-12-31 | −70.98% | +98.15 pp |
| 2023 | 2023-12-31 | −169.13% | −38.20 pp |
| 2022 | 2022-12-31 | −130.94% | −68.86 pp |
| 2021 | 2021-12-31 | −62.07% | −2.18 pp |
| 2020 | 2020-12-31 | −59.89% | — |
Praxis Precision Medicines quarterly return on equity
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −6.09% | +10.78 pp |
| Q1 2026 | 2026-03-31 | −8.09% | +7.58 pp |
| Q4 2025 | 2025-12-31 | −14.56% | −0.38 pp |
| Q3 2025 | 2025-09-30 | −19.78% | −6.83 pp |
| Q2 2025 | 2025-06-30 | −16.87% | −6.79 pp |
| Q1 2025 | 2025-03-31 | −15.67% | +10.76 pp |
| Q4 2024 | 2024-12-31 | −14.17% | +20.19 pp |
| Q3 2024 | 2024-09-30 | −12.95% | +12.66 pp |
| Q2 2024 | 2024-06-30 | −10.07% | +30.27 pp |
| Q1 2024 | 2024-03-31 | −26.43% | +26.86 pp |
| Q4 2023 | 2023-12-31 | −34.37% | +11.06 pp |
| Q3 2023 | 2023-09-30 | −25.61% | +10.41 pp |
| Q2 2023 | 2023-06-30 | −40.34% | −3.85 pp |
| Q1 2023 | 2023-03-31 | −53.29% | −22.18 pp |
| Q4 2022 | 2022-12-31 | −45.43% | −24.00 pp |
| Q3 2022 | 2022-09-30 | −36.02% | −21.82 pp |
| Q2 2022 | 2022-06-30 | −36.49% | −24.35 pp |
| Q1 2022 | 2022-03-31 | −31.11% | −21.21 pp |
| Q4 2021 | 2021-12-31 | −21.43% | +9.88 pp |
| Q3 2021 | 2021-09-30 | −14.20% | — |
| Q2 2021 | 2021-06-30 | −12.15% | — |
| Q1 2021 | 2021-03-31 | −9.90% | — |
| Q4 2020 | 2020-12-31 | −31.31% | — |
Praxis Precision Medicines return on equity trends
Over the last five fiscal years, Praxis Precision Medicines's return on equity increased from −59.89% to −45.83%, a change of +14.06 percentage points. The latest reported quarter, Q2 2026, shows −6.09%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Praxis Precision Medicines source filings ↗